Unlike TTP, in which angiotensin-converting enzyme (ACE) inhibitors were associated with lower in-hospital mortality, we could not demonstrate any impact from the choice of anti-hypertensive drug used in STEC-HUS patients, but the long-term use of ACE inhibitors has been associated with a reno-protective effect [221]. This evidence concerns the gene ACE and hemolytic-uremic syndrome.